Skip to main content

Advertisement

Log in

Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Nanostructured lipid carriers (NLCs) are interesting delivery systems for enhancing the penetration of an active substance through the skin after topical administration. The present paper described the development of a novel NLCs for minoxidil (MXD) topical delivery. Stearic acid and oleic acid that showed the highest solubility for MXD were selected as solid lipid and liquid lipid, respectively, and the NLCs were prepared by hot high pressure homogenization method. The minoxidil loaded NLCs prepared accordingly to the optimal formulation exhibited spherical shape with a mean diameter of 281.4 ± 7.4 nm, polydispersity of 0.207 ± 0.009, zeta potential of −32.90 ± 1.23 mV, drug entrapment efficiency of 92.48 ± 0.31%, and drug loading of 13.85 ± 0.47%. Storage stability studies demonstrated that the particle size and entrapment efficiency of the MXD-NLCs were not changed during 3 months both at 4°C and room temperature. Moreover, the release of MXD from the NLCs was faster than drug release from SLNs. In vitro skin permeability test demonstrated that MXD-NLCs had a more pronounced permeation and retention profile than MXD-SLNs. Furthermore, no erythema was observed after administration of MXD-NLCs. All these results indicated that the developed MXD-NLCs could be a promising and effective nanocarrier for topical delivery of MXD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Sundberg JP, Beamer WG, Uno H, Van Neste D, King LE. Androgenetic alopecia: in vivo models. Exp Mol Pathol. 1999;67(2):118–30.

    Article  CAS  PubMed  Google Scholar 

  2. Sinclair RD, Dawber RPR. Androgenetic alopecia in men and women. Clin Dermatol. 2001;19(2):167–78.

    Article  CAS  PubMed  Google Scholar 

  3. Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol. 2002;37(8–9):981–90.

    Article  PubMed  Google Scholar 

  4. Redler S, Dobson K, Drichel D, Heilmann S, Wolf S, Brockschmidt FF, et al. Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss. J Dermatol Sci. 2013;72(2):186–8.

    Article  CAS  PubMed  Google Scholar 

  5. Padois K, Cantiéni C, Bertholle V, Bardel C, Pirot F, Falson F. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int J Pharm. 2011;416(1):300–4.

    CAS  PubMed  Google Scholar 

  6. Yoon G, Park JW, Yoon I-S. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm Investig. 2013;43(5):353–62.

    Article  CAS  Google Scholar 

  7. Elmowafy M, Samy A, Raslan MA, Salama A, Said RA, Abdelaziz AE, et al. Enhancement of bioavailability and pharmacodynamic effects of thymoquinone via nanostructured lipid carrier (NLC) formulation. AAPS PharmSciTech. 2015; 1–10. doi:10.1208/s12249-015-0391-0.

  8. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2–3):165–96.

    Article  CAS  PubMed  Google Scholar 

  9. de Jesus MB, Zuhorn IS. Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms. J Control Release. 2015;201:1–13.

    Article  PubMed  Google Scholar 

  10. Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47(1):139–51.

    Article  CAS  PubMed  Google Scholar 

  11. Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59(6):427–43.

    Article  PubMed  Google Scholar 

  12. Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ. Solid lipid nanoparticles and nanostructured lipid carriers—innovative generations of solid lipid carriers. Curr Drug Deliv. 2008;5(4):324–31.

    Article  CAS  PubMed  Google Scholar 

  13. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1–2):170–84.

    Article  CAS  PubMed  Google Scholar 

  14. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:131–55.

    Article  Google Scholar 

  15. Patlolla RR, Chougule M, Patel AR, Jackson T, Tata PN, Singh M. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release. 2010;144(2):233–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Salunkhe SS, Bhatia NM, Pokharkar VB, Thorat JD, Bhatia MS. Topical delivery of Idebenone using nanostructured lipid carriers: evaluations of sun-protection and anti-oxidant effects. J Pharm Investig. 2013;43(4):287–303.

    Article  CAS  Google Scholar 

  17. Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V. Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomed: Nanotechnol Biol Med. 2016;12(1):143–61.

    CAS  Google Scholar 

  18. Pardeike J, Weber S, Matsko N, Zimmer A. Formation of a physical stable delivery system by simply autoclaving nanostructured lipid carriers (NLC). Int J Pharm. 2012;439:22–7.

    Article  CAS  PubMed  Google Scholar 

  19. Li B, Ge ZQ. Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone. AAPS PharmSciTech. 2012;13(1):276–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328(2):191–5.

    Article  CAS  PubMed  Google Scholar 

  21. Lauterbach A, Müller-Goymann CC. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Eur J Pharm Biopharm. 2015;97:152–63.

    Article  CAS  PubMed  Google Scholar 

  22. Chen H, Wang Y, Zhai Y, Zhai G, Wang Z, Liu J. Development of a ropivacaine-loaded nanostructured lipid carrier formulation for transdermal delivery. Colloids Surf A. 2015;465:130–6.

    Article  CAS  Google Scholar 

  23. Chen Y, Yang X, Zhao L, Almásy L, Garamus VM, Willumeit R, et al. Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug. Colloids Surf A. 2014;455:36–43.

    Article  CAS  Google Scholar 

  24. Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2011;12:62–76.

    Article  CAS  PubMed  Google Scholar 

  25. Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 2010;394(1):179–85.

    Article  CAS  PubMed  Google Scholar 

  26. Lee SG, Jeong JH, Kim SR, Lee KM, Ahn BK, Kang MH, et al. Topical formulation of retinyl retinoate employing nanostructured lipid carriers. J Pharm Investig. 2012;42(5):243–50.

    Article  CAS  Google Scholar 

  27. How CW, Rasedee A, Manickam S, Rosli R. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity. Colloids Surf B. 2013;112:393–9.

    Article  CAS  Google Scholar 

  28. Han F, Yin R, Che X, Yuan J, Cui Y, Yin H, et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Int J Pharm. 2012;439(1):349–57.

    Article  CAS  PubMed  Google Scholar 

  29. Patel HK, Barot BS, Parejiya PB, Shelat PK, Shukla A. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo—part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies. Colloids Surf B. 2014;119:145–53.

    Article  CAS  Google Scholar 

  30. Ahaghotu E, Babu RJ, Chatterjee A, Singh M. Effect of methyl substitution of benzene on the percutaneous absorption and skin irritation in hairless rats. Toxicol Lett. 2005;159(3):261–71.

    Article  CAS  PubMed  Google Scholar 

  31. Babu RJ, Chatterjee A, Singh M. Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane. Toxicol Lett. 2004;153(2):255–66.

    Article  CAS  PubMed  Google Scholar 

  32. Chakraborty S, Shukla D, Mishra B, Singh S. Lipid: an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm. 2009;73(1):1–15.

    Article  CAS  PubMed  Google Scholar 

  33. Negi LM, Jaggi M, Talegaonkar S. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int J Pharm. 2014;461(1):403–10.

    Article  CAS  PubMed  Google Scholar 

  34. Vitorino C, Almeida A, Sousa J, Lamarche I, Gobin P, Marchand S, et al. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Eur J Pharm Biopharm. 2014;86(2):133–44.

    Article  CAS  PubMed  Google Scholar 

  35. Gomes MJ, Martins S, Ferreira D, Segundo MA, Reis S. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine. 2014;9:1231–42.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Selvamuthukumar S, Velmurugan R. Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy. Lipids Health Dis. 2012;11:159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–37.

    Article  Google Scholar 

  38. Trommer H, Neubert RHH. Overcoming the stratum corneum: the modulation of skin penetration. Skin Pharmacol Physiol. 2006;19(2):106–21.

    Article  CAS  PubMed  Google Scholar 

  39. Kyadarkunte AY, Patole MS, Pokharkar VB. Cellular interactions and photoprotective effects of idebenone-loaded nanostructured lipid carriers stabilized using PEG-free surfactant. Int J Pharm. 2015;479(1):77–87.

    Article  CAS  PubMed  Google Scholar 

  40. Zhang XY, Qiao H, Ni JM, Shi YB, Qiang Y. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. Eur J Pharm Sci. 2013;49(3):411–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinyan Huang.

Ethics declarations

Compliance with Ethical Standards

The study was evaluated and approved by the Ethics Committee of the Zhejiang University of Technology.

Conflict of Interest

The authors report no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Chen, L., Huang, X. et al. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers. AAPS PharmSciTech 18, 509–516 (2017). https://doi.org/10.1208/s12249-016-0519-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-016-0519-x

KEY WORDS

Navigation